Cambridge Trust’s Balchem Corp BCPC Stock Holding History

Cambridge Trust’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-70	Closed	-$12K	–	1204
2021 Q4	$12K	Buy	+70	New	+$11.2K	﹤0.01%	789

Other funds holding BCPC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Cambridge Trust's BCPC Position: Q1 2022 in Review

Cambridge Trust sold out of Balchem Corp (BCPC) in Q1 2022, closing a stake of 70 shares — an estimated $12K sold.

Cambridge Trust first reported a position in BCPC in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 299 funds tracked by Wall St. Rank hold BCPC as of Q1 2022.

Cambridge Trust reported no remaining Balchem Corp position as of Q1 2022 after selling out during the quarter.
Cambridge Trust sold 70 Balchem Corp shares in Q1 2022, an estimated $12K.
Cambridge Trust first reported a position in Balchem Corp in Q4 2021 and held it in 1 quarter.
Cambridge Trust's Balchem Corp position peaked at $12K in Q4 2021.
299 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2022.

Based on Cambridge Trust's 13F filing for Q1 2022, filed 12 May 2022.